FDA
-
-
-
-
-
-
-
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
-
-
-
-
-
-
-
Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
GlucoTrack (GCTK) Appoints Andy Balo to its Board
-
-
-
-
-
-
-
GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
-
-
-
-
-
-
-
GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR
-
-
-
-
-
-
-
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
-
-
-
-
-
-
-
GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change
-
328,614 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

